Stock Screener App

Frei -

Installieren

3.44

2.69% 0.09

Relmada Therapeutics Inc (RLMD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Relmada Therapeutics Inc-Aktie (RLMD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	22.87% 15.01	19.46	20.33	10.33	10.22
Operating Income/Loss	22.87% -15.01	-19.46	-20.33	-10.33	-10.22
Nonoperating Income/Loss	411.68% 2.0968	0.4098	0.4654	0.2359	0.3549
Net Income/Loss	32.22% -12.91	-19.05	-19.87	-10.09	-9.8664
Basic Average Shares	29.77% 112.38	86.60	-	33.19	33.19
Diluted Average Shares	29.77% 112.38	86.60	-	33.19	33.19
Basic Earnings Per Share	50.00% -0.11	-0.22	-	-0.30	-0.30
Diluted Earnings Per Share	50.00% -0.11	-0.22	-	-0.30	-0.30

OLMA

$7.33

2.14%

BCAX

$9.73

0.31%

DBVT

$10.29

3.38%

AURA

$6.295

1.64%

SLBT

$1.17

3.31%

LXRX

$1.48

0.34%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters